Nidhi Saini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nidhi Saini has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Suresh Kumar Gahlawat
Department of Biotechnology, Chaudhary Devi Lal University, Sirsa, Haryana, India
2 shared publications Viney Lather
Department of Pharmaceutical, Amity University, Noida, India
2 shared publications- Ajmer Singh Grewal
Guru Gobind Singh College ofPharmacy, Yamuna Nagar, Haryana, India
1 shared publication Suresh Kumar Gahlawat
Department of Biotechnology, Chaudhary Devi Lal University, Sirsa 125055, India
1 shared publication- Viney Lather
Amity Institute of Pharmacy, Amity University Uttar Pradesh, Sector-125, Noida, 201313, India
1 shared publication
Latest Publications
- 1 May 2022
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 22 (9) , 1674-1698
Exploring Phytochemicals from Himalayan Medicinal Plants as Novel Therapeutic Agents
Over-prescription of medicines leads to some crucial health issues like resistance, non-specificity, etc. Therefore, a human consumes various natural foods, therapeutics, and nutritional supplements to combat this problem. Various therapeutic properties of secondary metabolites, such as anticancer, anti-inflammatory, and antibacterial properties, are important in drug discovery and medicinal application. These natural products have replaced synthetic materials, resulting in a great deal of sustainability, rational use, and preservation of biodiversity. This review described the potential therapeutic applications of secondary plant metabolites found in Himalayan Indian plants. The database contains 45 plants to treat various diseases, such as cancer, inflammation, and microbial infections. Besides authorized ITIS names, it includes Hindi names, family names, and active constituents. The most important information about the molecules can be found in the hyperlinks for the active constituents. It includes structures (two-dimensional and threedimensional), names and identifiers, chemical and physical properties, spectral information, biochemistry, literature and patents. The review also references various phytochemicals responsible for preventing COVID-19. Despite several challenges in manufacturing natural products, researchers may conduct research to produce successful medicines with few side effects.
- 1 May 2022
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 22 (9) , 1674-1698
Exploring Phytochemicals from Himalayan Medicinal Plants as Novel Therapeutic Agents
Over-prescription of medicines leads to some crucial health issues like resistance, non-specificity, etc. Therefore, a human consumes various natural foods, therapeutics, and nutritional supplements to combat this problem. Various therapeutic properties of secondary metabolites, such as anticancer, anti-inflammatory, and antibacterial properties, are important in drug discovery and medicinal application. These natural products have replaced synthetic materials, resulting in a great deal of sustainability, rational use, and preservation of biodiversity. This review described the potential therapeutic applications of secondary plant metabolites found in Himalayan Indian plants. The database contains 45 plants to treat various diseases, such as cancer, inflammation, and microbial infections. Besides authorized ITIS names, it includes Hindi names, family names, and active constituents. The most important information about the molecules can be found in the hyperlinks for the active constituents. It includes structures (two-dimensional and threedimensional), names and identifiers, chemical and physical properties, spectral information, biochemistry, literature and patents. The review also references various phytochemicals responsible for preventing COVID-19. Despite several challenges in manufacturing natural products, researchers may conduct research to produce successful medicines with few side effects.
- 24 March 2022
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 358, 109901
Natural alkaloids targeting EGFR in non-small cell lung cancer: Molecular docking and ADMET predictions
- 24 March 2022
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 358, 109901
Natural alkaloids targeting EGFR in non-small cell lung cancer: Molecular docking and ADMET predictions
- 3 June 2017
- Published by Springer Nature
- p. 255-270
Flavonoids: A Nutraceutical and Its Role as Anti-inflammatory and Anticancer Agent
- 3 June 2017
- Published by Springer Nature
- p. 255-270
Flavonoids: A Nutraceutical and Its Role as Anti-inflammatory and Anticancer Agent